PKA RI beta Antibody [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # AF4177M

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human PKA RI beta
Met1-Val381
Accession # P31321
Met1-Val381
Accession # P31321
Specificity
Detects human, mouse, and rat PKA RI beta in Western blots. In Western blots, less than 1% cross-reactivity with recombinant human (rh) PKA RI alpha or rhPKA RII beta is observed; cross-reactivity with PKA RII alpha is unknown.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for PKA RI beta Antibody [DyLight 594]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PKA RI beta
Long Name
cAMP-dependent Protein Kinase Regulatory Type I beta
Alternate Names
PRKAR1B, RIbeta
Gene Symbol
PRKAR1B
Additional PKA RI beta Products
Product Documents for PKA RI beta Antibody [DyLight 594]
Product Specific Notices for PKA RI beta Antibody [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...